<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03815565</url>
  </required_header>
  <id_info>
    <org_study_id>65821217.5.0000.8066</org_study_id>
    <nct_id>NCT03815565</nct_id>
  </id_info>
  <brief_title>Continuous Femoral Block With Levobupivacaine 0.125% or Ropivacaine 0.2% in Elderly Patients With Femoral Fractures</brief_title>
  <official_title>Comparison Between Continuous Femoral Block With Levobupivacaine 0.125% and Ropivacaine 0.2% for Preoperative Analgesia, in Patients Over 70 Years Old, With Proximal Femoral Fractures: a Randomized, Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Municipal Miguel Couto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Municipal Miguel Couto</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the continuous femoral block between levobupivacaine 0.125% and
      ropivacaine 0.2% in patients with proximal femoral fracture.These patients will be divided
      into 2 groups of 35 patients, one L group (levobupivacaine 0.125%) and one R group
      (ropivacaine 0.2%) distributed randomly, receiving continuous infusion through patient
      controlled analgesia (PCA) pump with the following parameters: infusion 5 ml / h, bolus 5 ml,
      lockout 30 min.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain is associated with neurohormonal stress, myocardial ischemia and delayed mobilization,
      thus being able to increase the hospitalization time and associated with increased
      postoperative mortality. Regional anesthesia through simple or continuous femoral nerve block
      are options for analgesia in patients with femoral fracture, as well as analgesia by venous
      opioids. A potential benefit of regional anesthesia is precisely to avoid the use of opioids
      and other general anesthetics, which in turn are also closely related to postoperative
      delirium. Continuous femoral block, since the preoperative period, is associated with the
      reduction of acute pain and opioid consumption, in patients with femoral neck fractures.
      There are few studies available in the literature comparing analgesic equipotency between
      levobupivacaine and ropivacaine in peripheral nerve blocks. In none of them, the peripheral
      analgesia in the femoral nerve, for proximal femoral fracture was compared.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 28, 2017</start_date>
  <completion_date type="Anticipated">January 8, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 8, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Only the pharmacist chief knows which participant belongs to each arm</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>intensity of individual pain episodes</measure>
    <time_frame>6 hours after hospital admission</time_frame>
    <description>Self report pain intensity in the preoperative period. Scored 0-10 (0 = no pain; 10 = pain as bad as can be)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of PCA firing</measure>
    <time_frame>72 hours</time_frame>
    <description>in each patient at time of evaluation of pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of satisfaction with analgesic therapy</measure>
    <time_frame>up to 72 hours - at the moment of surgery; or at the end of 72 hours</time_frame>
    <description>using the 5-point rating scale (very dissatisfied, dissatisfied, neutral, satisfied or very pleased)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of sleep</measure>
    <time_frame>up to 72 hours</time_frame>
    <description>very good, good, bad and very bad</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the cost of analgesic therapy</measure>
    <time_frame>up to 72 hours</time_frame>
    <description>including catheters, PCA and medication in each patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse event</measure>
    <time_frame>up to 72 hours</time_frame>
    <description>paresthesia, nausea, vomiting, ringing in the ear, metallic taste, convulsion or cardiac arrest</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Femur Fracture</condition>
  <condition>Hip Fractures</condition>
  <arm_group>
    <arm_group_label>levobupivacaine 0.125%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>continuous femoral block with levobupivacaine 0.125%. Use of PCA pump with the following parameters: 5 ml/h; bolus 5 ml; lockout 30 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ropivacaine 0.2%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>continuous femoral block with ropivacaine 0.2%. Use of PCA pump with the following parameters: 5 ml/h; bolus 5 ml; lockout 30 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>continuous femoral block</intervention_name>
    <description>infusion of anesthetic by PCA pump</description>
    <arm_group_label>levobupivacaine 0.125%</arm_group_label>
    <arm_group_label>ropivacaine 0.2%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  70 years old or more

          -  patients with femur fracture

          -  physical status risk American Society of Anesthesiologists (ASA) P1 - P3

        Exclusion Criteria:

          -  physical status ASA P4

          -  patients with BMI &gt; 35

          -  systemic infection

          -  Injury or infection at the site of installation of the femoral perineural catheter

          -  Catheter displacement of the perineural site

          -  Montreal Cognitive Assessment (MoCA) &lt; 26

          -  Patients operated before 24 hours of hospital admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rafael Linhares</last_name>
    <phone>+55 21 981436088</phone>
    <email>rafaellinhares@me.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ismar Cavalcanti</last_name>
    <phone>+55 21 999822993</phone>
    <email>ismarcavalcanti@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rafael M Linhares</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>22776050</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael Linhares</last_name>
      <phone>+55 21 981436088</phone>
      <email>rafaellinhares@me.com</email>
    </contact>
    <contact_backup>
      <last_name>Ismar Cavalcanti</last_name>
      <phone>+55 21 999822993</phone>
      <email>ismarcavalcanti@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Joshi G, Gandhi K, Shah N, Gadsden J, Corman SL. Peripheral nerve blocks in the management of postoperative pain: challenges and opportunities. J Clin Anesth. 2016 Dec;35:524-529. doi: 10.1016/j.jclinane.2016.08.041. Epub 2016 Oct 20. Review.</citation>
    <PMID>27871587</PMID>
  </reference>
  <results_reference>
    <citation>Ritcey B, Pageau P, Woo MY, Perry JJ. Regional Nerve Blocks For Hip and Femoral Neck Fractures in the Emergency Department: A Systematic Review. CJEM. 2016 Jan;18(1):37-47. doi: 10.1017/cem.2015.75. Epub 2015 Sep 2. Review.</citation>
    <PMID>26330019</PMID>
  </results_reference>
  <results_reference>
    <citation>Morrison RS, Magaziner J, McLaughlin MA, Orosz G, Silberzweig SB, Koval KJ, Siu AL. The impact of post-operative pain on outcomes following hip fracture. Pain. 2003 Jun;103(3):303-11.</citation>
    <PMID>12791436</PMID>
  </results_reference>
  <results_reference>
    <citation>Szucs S, Iohom G, O'Donnell B, Sajgalik P, Ahmad I, Salah N, Shorten G. Analgesic efficacy of continuous femoral nerve block commenced prior to operative fixation of fractured neck of femur. Perioper Med (Lond). 2012 Jun 27;1:4. doi: 10.1186/2047-0525-1-4. eCollection 2012.</citation>
    <PMID>24764520</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 8, 2019</study_first_submitted>
  <study_first_submitted_qc>January 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 24, 2019</study_first_posted>
  <last_update_submitted>February 18, 2020</last_update_submitted>
  <last_update_submitted_qc>February 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Municipal Miguel Couto</investigator_affiliation>
    <investigator_full_name>Rafael Mercante Linhares</investigator_full_name>
    <investigator_title>Head of Anesthesiology and Pain Medicine Department</investigator_title>
  </responsible_party>
  <keyword>analgesia</keyword>
  <keyword>continuous</keyword>
  <keyword>femoral block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
    <mesh_term>Femoral Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>after the finish of the study</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

